Corrigendum: Long term outcome of Aldosteronism after target treatments
Journal
Scientific reports
Journal Volume
7
Pages
45249
Date Issued
2017
Author(s)
Chang, Chia-Hui
Hu, Ya-Hui
Chen, Likwang
Abstract
Scientific Reports 6: Article number: 32103; published online: 02 September 2016; updated: 24 March 2017 The original version of this Article contained an error in the Abstract. “While need for receptor antagonist (MRA) MRA after diagnosis suggests that a defined daily dose (DDD) of MRA between 12.5and 50 mg may alleviate risk of death in a U-shape pattern”.
SDGs
Publisher
NLM (Medline)
Type
corrigendum